neonat
calf
diarrhoea
ncd
defin
paper
diarrhoea
calv
age
younger
complex
diseas
trigger
infecti
noninfecti
caus
preval
incid
risk
ncd
dairi
cattl
herd
recent
report
respect
calv
age
day
enter
common
caus
death
case
fatal
risk
ncd
peak
probabl
die
due
enter
second
week
life
enterotox
escherichia
coli
rota
coronaviru
cryptosporidium
spp
c
parvum
import
enteropathogen
caus
ncd
worldwid
rotaviru
c
parvum
frequent
identifi
faecal
sampl
young
calv
escherichia
coli
typic
caus
diarrhoea
calv
day
old
three
caus
diarrhoea
often
calv
neonat
calf
diarrhoea
preval
e
coli
rota
coronaviru
c
parvum
rang
respect
howev
enteropathogen
commonli
implic
ncd
outbreak
also
found
faecal
sampl
healthi
calv
mean
presenc
pathogen
alway
caus
less
common
enteropathogen
caus
ncd
salmonella
spp
attach
effac
e
coli
among
enteropathogen
e
coli
enterohemorrhag
e
coli
shiga
toxin
produc
e
coli
clostridium
difficil
clostridium
perfringen
toroviru
veterinarian
import
advisori
role
daili
prevent
treatment
challeng
practic
aim
review
therefor
provid
critic
analysi
recent
literatur
prevent
treatment
ncd
emphasi
colostrum
manag
fluid
therapi
web
scienc
http
webofknowledgecom
search
septemb
calf
neonat
diarrhoea
fluid
therapi
refer
follow
calf
neonat
diarrhoea
colostrum
refer
subjectspecif
term
articl
publish
peer
review
journal
past
decad
consid
retain
reliabl
recent
advanc
prevent
treatment
ncd
refer
literatur
review
case
report
includ
scan
miss
refer
refer
relev
screen
conduct
first
author
withhold
english
paper
deal
colostrum
manag
fluid
therapi
conjunct
neonat
diarrhoea
dairi
calv
refer
public
statu
restrict
although
import
good
colostrum
manag
lead
adequ
passiv
transfer
undebat
prevent
ncd
studi
show
signific
effect
colostrum
feed
routin
risk
diarrhoea
risk
shed
c
parvum
lack
signific
effect
explain
high
number
diarrhoea
case
caus
c
parvum
colostr
igg
less
protect
fpt
preval
consid
ration
achiev
goal
use
cutoff
valu
g
iggl
howev
sever
studi
propos
serum
igg
concentr
gl
cutoff
point
defin
failur
passiv
transfer
fpt
percentag
fpt
rang
depend
cutoff
valu
popul
studi
andor
method
use
estim
calf
serum
igg
level
odd
fpt
higher
onfarm
routin
screen
therefor
igg
concentr
calv
estim
regularli
test
complianc
colostrum
manag
practic
field
determin
serum
total
protein
use
refractomet
colostrum
also
contain
benefici
constitu
higher
concentr
normal
milk
immunolog
activ
leukocyt
fat
protein
fatsolubl
vitamin
eg
retinol
tocopherol
watersolubl
vitamin
eg
niacin
thiamin
riboflavin
vitamin
pyridox
pyridoxamin
pyridoxin
miner
eg
ca
p
mg
na
k
zn
fe
cu
mn
nonspecif
antimicrobi
factor
eg
lactoferrin
function
import
colostr
leukocyt
yet
fulli
understood
studi
show
enhanc
lymphocyt
respons
nonspecif
mitogen
specif
antigen
increas
antigenpres
capac
other
suggest
role
fresh
colostr
leukocyt
may
import
thought
protect
c
parvum
mainli
cellmedi
research
import
colostr
leukocyt
warrant
colostr
igg
concentr
import
factor
affect
whether
calv
receiv
suffici
passiv
immun
colostrum
unfortun
amount
igg
matern
colostrum
vari
dramat
among
cow
gl
sampl
reach
desir
amount
g
iggl
colostr
qualiti
difficult
estim
farmer
base
produc
volum
appear
colostrum
use
weight
first
milk
screen
test
identifi
bovin
colostrum
inadequ
igg
concentr
justifi
low
sensit
somat
cell
count
measur
calv
significantli
higher
cow
produc
colostrum
inferior
qualiti
compar
produc
highqual
colostrum
reason
better
measur
colostr
igg
content
indirectli
use
colostromet
g
iggl
densiti
brix
refractomet
g
iggl
brix
directli
cowsid
immunoassay
kit
singl
line
igg
concentr
g
iggl
measur
colostrum
qualiti
avoid
use
forestrip
sampl
test
purpos
sampl
may
overestim
igg
concentr
colostrum
collect
hour
calv
significantli
lower
colostr
igg
concentr
probabl
dilut
effect
colostr
ig
diffus
passiv
cow
system
circul
colostrum
milk
soon
possibl
calv
colostrum
cow
without
dri
period
lower
igg
concentr
compar
colostrum
cow
dri
period
day
pool
colostrum
advis
sinc
risk
factor
fpt
cow
pariti
older
usual
significantli
higher
level
igg
per
liter
colostrum
heifer
pariti
cow
reflect
calv
born
heifer
greater
risk
fpt
calv
born
multipar
cow
howev
correl
pariti
colostrum
igg
concentr
alway
evid
discard
colostrum
heifer
thu
advis
colostrum
replac
product
highli
variabl
perform
herd
veterinarian
advis
consult
result
peerreview
control
trial
separ
product
colostrum
supplement
milk
replac
first
week
life
g
igg
bid
reduc
ncd
rate
intestin
activ
colostr
antibodi
epitheli
growth
promot
substanc
critic
control
point
bacteri
contamin
colostrum
harvest
storag
process
store
colostrum
ambient
temperatur
result
signific
increas
bacteria
fresh
colostrum
store
hour
potassium
sorbat
ad
preserv
industri
recommend
bacteri
load
limit
coloni
form
unit
cfu
ml
depend
time
sampl
use
storag
method
colostrum
sampl
exceed
maximum
advis
bacteri
count
cfuml
pasteur
colostrum
min
reduc
bacteri
load
viscos
colostr
igg
concentr
remain
within
accept
limit
feed
higherqu
batch
colostrum
suffer
significantli
greater
magnitud
loss
igg
compar
lower
intermedi
qualiti
batch
colostrum
calv
fed
pasteur
colostrum
significantli
higher
serum
igg
concentr
serum
protein
valu
andor
greater
appar
effici
absorpt
compar
calv
fed
unpasteur
colostrum
probabl
explain
bacteria
bind
free
igg
gut
lumen
block
uptak
transport
igg
molecul
across
intestin
epitheli
cell
moreov
calv
fed
pasteur
colostrum
significantli
decreas
risk
treatment
diarrhoea
calv
allow
nurs
dam
higher
odd
fpt
calv
separ
dam
within
hour
birth
allow
nurs
calv
drink
late
littl
colostrum
feed
calv
much
colostrum
want
nippl
bottl
within
hour
birth
hour
age
substanti
reduc
probabl
fpt
bottl
fed
calv
ingest
colostrum
voluntarili
tube
fed
feed
least
g
colostr
igg
requir
adequ
passiv
transfer
colostr
igg
colostrum
administ
oesophag
intub
hour
birth
estim
exact
amount
igg
given
calf
colostrum
qualiti
measur
explain
higher
colostrum
contain
g
iggl
feed
l
colostrum
suffic
provid
g
igg
calf
ad
benefit
feed
l
colostrum
compar
l
colostrum
compar
qualiti
fed
use
oesophag
tube
larger
igg
intak
requir
calv
fed
hour
birth
hand
feed
colostrum
hour
birth
risk
factor
fpt
slight
delay
increas
serum
ig
concentr
obviou
calv
receiv
l
colostrum
oesophag
intub
compar
bottlef
calv
receiv
l
howev
calv
receiv
colostrum
oesophag
intub
reach
significantli
higher
ig
concentr
compar
bottlef
calv
differ
administ
volum
l
versu
l
two
method
oesophag
intub
versu
bottlef
conclud
studi
appropri
use
oesophag
tube
feed
l
colostrum
safe
reliabl
method
adequ
passiv
immun
transfer
healthi
newborn
calv
studi
prove
colostrum
fed
oesophag
intub
better
bottlefeed
colostrum
research
need
reveal
rapid
passag
ig
reticulorumen
abomasum
also
occur
weak
born
calv
moreov
tube
feed
caus
moder
depress
difficult
adapt
feed
nippl
bucket
calv
care
femal
worker
less
like
develop
fpt
probabl
women
patient
newborn
calv
refus
suckl
odd
fpt
higher
calv
experienc
dystocia
explain
drink
littl
colostrum
andor
lower
appar
effici
absorpt
administr
oral
rehydr
solut
or
commenc
soon
diarrhoea
start
continu
long
calf
diarrhoea
osmol
or
determin
primarili
concentr
sodium
glucos
calv
fed
hyperosmot
or
solut
mosml
hor
slower
abomas
empti
rate
compar
calv
fed
isoosmot
or
solut
mosml
ior
slower
empti
rate
increas
risk
bloat
abomas
produc
slower
rate
plasma
volum
expans
unless
previous
assum
volum
present
reticulorumen
healthi
calv
intub
appear
predominantli
due
reflux
abomasum
rather
spillag
incomplet
closur
oesophag
groov
calcul
chang
abomas
volum
intub
calv
approxim
one
calv
suckl
or
contrast
deliveri
hor
small
intestin
slower
intub
indic
differ
effect
intub
coordin
motil
reticulorumen
abomasum
duodenum
suckl
effect
taken
togeth
suckl
ior
provid
fastest
rate
solut
deliveri
small
intestin
slightli
faster
rate
plasma
volum
expans
suckl
oesophag
intub
hor
howev
suckl
oesophag
intub
hor
provid
appropri
oral
solut
treat
hypoglycaem
calv
hor
produc
larger
sustain
increas
plasma
glucos
concentr
alkalin
agent
commonli
use
commerci
or
bicarbon
bicarbon
precursor
mainli
acet
propion
citrat
phosphat
higher
assum
alkalinis
or
product
contain
bicarbon
bor
citrat
cor
compar
solut
contain
bicarbon
precursor
confirm
recent
studi
absolut
number
never
significantli
differ
high
sidfluid
mmoll
recommend
treat
acidosi
sid
valu
or
determin
degre
abomas
serum
alkalinis
prolong
vivo
clot
time
like
occur
larger
volum
or
cow
milk
fed
lumin
ph
initi
greater
remain
greater
longer
period
time
studi
care
conclud
feed
bor
cor
affect
milk
clot
vivo
disagre
gener
recommend
feed
bor
cor
concurr
short
beforeaft
cow
milk
calv
sid
valu
fed
amount
or
seem
play
import
role
correct
dehydr
metabol
acidosi
note
research
discuss
execut
small
number
healthi
nondiarrho
calv
milk
clot
abomas
lumin
ph
abomas
empti
rate
could
differ
diarrhoeic
nondiarrho
calv
intraven
iv
fluid
therapi
implement
calf
sever
dehydr
depress
weakenedabs
suckl
reflex
suffer
dilat
abomasum
andor
intestin
hypomotil
fluid
alway
warm
eg
ad
coil
iv
fluid
line
place
bucket
hot
water
calf
need
use
extra
energi
bring
given
fluid
bodi
temperatur
sustain
improv
clinic
statu
iv
fluid
therapi
need
follow
continu
or
therapi
jugular
auricular
vein
catheter
iv
rehydr
use
ear
vein
larger
quantiti
fluid
given
longer
period
time
farm
set
bicarbon
requir
iv
correct
acidosi
still
calcul
follow
bicarbon
g
bodi
weight
kg
mmoll
lkg
gmmol
use
formula
metabol
acidosi
correct
half
calv
risk
failur
correct
acidosi
increas
dlactat
concentr
calv
distinct
chang
postur
demeanour
thu
seem
need
higher
dose
bicarbon
calcul
factor
formula
mention
howev
studi
followup
therapi
or
offer
could
explain
calv
becom
acidot
h
studi
report
treatment
failur
sever
metabol
acidosi
treatment
compar
success
treat
calv
formula
mention
use
estim
buffer
requir
correct
incur
loss
overdos
seem
desir
underdos
bicarbon
given
iv
isoton
ib
hyperton
solut
hb
field
practic
use
hb
compar
ib
rapid
iv
administr
bicarbon
formul
mlkg
provid
effect
safe
method
improv
abnorm
direct
indic
studi
potenti
advers
effect
relat
electrolyt
concentr
oxygenhaemoglobin
dissoci
curv
hypercapnia
paradox
intracellular
acidosi
previous
assum
conclud
studi
hb
safe
use
speed
iv
administr
exceed
mlkgmin
calv
suffer
respiratori
problem
hypoglycaemia
best
address
give
mg
glucosekg
larger
quantiti
glucos
avoid
risk
glycosuria
calv
cachect
reluct
drink
also
given
constant
glucos
infus
use
ear
vein
approach
discuss
earlier
routin
use
ab
diarrhoeic
calv
recommend
due
increas
level
antibiot
resist
howev
system
ill
calv
depress
anorexia
fever
often
suffer
e
coli
septicaemia
thu
parenter
gramnegativespectrum
ab
advis
treat
calv
antimicrobi
suscept
test
method
perform
herd
level
regular
basi
mention
halofuginon
lactat
regist
product
prevent
treatment
c
parvum
europ
metaanalysi
effect
therapeut
halofuginon
treatment
conduct
result
consid
uninterpret
lack
suffici
data
azithromycin
mgd
day
per
oral
po
lasalocid
mgkg
sid
day
po
reduc
oocyst
shed
therapeut
use
nitazoxanid
mgkg
bid
po
day
improv
clinic
appear
intens
oocyst
excret
contrast
calv
therapeut
group
show
longer
diarrhoeic
episod
compar
untreat
control
group
antivir
drug
treat
rota
coronaviru
commerci
avail
nonsteroid
antiinflammatori
drug
nsaid
like
meloxicam
mgkg
oneshot
sc
improv
appetit
growth
rate
probabl
ncd
accompani
malais
gastrointestin
discomfort
despit
widespread
use
valid
recent
research
avail
recommend
product
reduc
intestin
motil
eg
hyoscin
nbutylbromid
literatur
contradictori
inconclus
concern
ancillari
treatment
phytopharmaceut
probiot
exampl
number
day
diarrhoea
sever
diarrhoea
mortal
rate
similar
oral
treatment
neomycin
dri
oregano
leav
howev
neg
control
group
receiv
treatment
includ
also
defin
calv
older
day
diarrhoea
suffer
colibacillosi
lactobacillu
rhamnosu
gg
affect
outcom
therapi
diarrhoeic
calv
herd
veterinarian
advis
consult
result
peerreview
control
trial
separ
product
overal
herd
veterinarian
focu
prevent
ncd
neonat
calf
diarrhoea
complex
diseas
high
morbid
mortal
dairi
cattl
herd
colostrum
manag
import
prevent
measur
often
neglect
also
therapi
manag
good
fluid
therapi
indispens
howev
mistak
often
made
herd
veterinarian
uptod
come
prevent
therapi
ncd
obviou
person
commun
item
dairi
farmer
